Lanean...

Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?

Colistin is administered as its inactive prodrug colistimethate (CMS). Selection of an individualized CMS dose for each patient is difficult due to its narrow therapeutic window, especially in patients with chronic kidney disease (CKD). Our aim was to analyze CMS use in patients with CKD. Secondary...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Molecules
Egile Nagusiak: Sorli, Luisa, Luque, Sonia, Li, Jian, Rodríguez, Eva, Campillo, Nuria, Fernandez, Xenia, Soldado, Jade, Domingo, Ignacio, Montero, Milagro, Grau, Santiago, Horcajada, Juan P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2019
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6384574/
https://ncbi.nlm.nih.gov/pubmed/30717123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24030530
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!